Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.010
+0.010 (0.25%)
At close: Oct 5, 2026, 4:00 PM EDT
4.010
0.00 (0.00%)
After-hours: Oct 5, 2026, 4:10 PM EDT
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $251.64 million as of October 5, 2026. Its market cap has increased by 77.30% in one year.
Market Cap
251.64M
Enterprise Value
167.61M
1-Year Change
77.30%
Ranking
Category
Stock Price
$4.01
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has increased from $208.55M to $251.64M, an increase of 20.66%. That is a compound annual growth rate of 9.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 251.64M | -20.88% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuneering | 263.32M |
| Vicore Pharma Holding AB | 261.45M |
| Pyxis Oncology | 255.64M |
| Sutro Biopharma | 254.52M |
| InflaRx | 253.47M |
| Evommune | 251.14M |
| Palisade Bio | 250.95M |
| Nautilus Biotechnology | 249.42M |